248 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Rank Status Study
21 Available Cartilage Tissue Engineering
Condition: Mesenchymal Stem Cells
Intervention: Other: total knee / hip replacement
22 Available Emergency/Compassionate Use PFO Occluder
Conditions: Patent;   Foramen;   Ovale;   PFO
Intervention: Device: Device closure with the AMPLATZER PFO Occluder
23 No longer available XL999 Administered Intravenously to a Subject With Advanced Malignancies
Condition: Advanced Malignancy
Intervention: Drug: XL999
24 Temporarily not available 99m-Technetium- Glucosamine in Arthritis
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis
Intervention: Device: Technetium labelled glucosamine
25 No longer available Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Conditions: Metastatic Liver Cancer;   Ocular Melanoma;   Cutaneous Melanoma
Interventions: Drug: Melphalan;   Device: Percutaneous Hepatic Perfusion
26 Temporarily not available An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient
Condition: Mucopolysaccharidosis Type 7
Intervention: Drug: UX003
27 Available Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Condition: Unresected Stage IIIb to IVM1c Melanoma
Intervention: Drug: Talimogene Laherparepvec
28 Temporarily not available Pulmonary Vein Isolation Outcomes With Fish Oils
Condition: Atrial Fibrillation
Intervention: Drug: Lovaza (Fish Oils)
29 Available Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Afatinib
30 No longer available Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: stiripentol
31 No longer available Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
Condition: Acquired Hemophilia A
Intervention: Biological: OBI-1
32 Available Ruxolitinib for Chuvash Polycythemia
Condition: Chuvash Polycythemia
Intervention: Drug: Ruxolitinib
33 No longer available A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
Conditions: Irritable Bowel Syndrome With Constipation;   Chronic Idiopathic Constipation
Intervention: Drug: Tegaserod
34 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculitis With Onset in Infancy (SAVI)
Intervention: Drug: Baricitinib
35 No longer available Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
Conditions: Field Actinic Keratoses;   Basal Cell Carcinoma;   Bowen's Disease
Intervention: Drug: Metvix (methyl aminolevulinate)
36 Available Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
Condition: Colorectal Neoplasms
Intervention: Drug: Regorafenib (BAY73-4506)
37 Temporarily not available Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer
Conditions: Breast Cancer;   Bone Metastasis
Intervention: Dietary Supplement: Chinese Herbs
38 Approved for marketing Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
Condition: Neoplasms
Intervention: Drug: Voraxaze (glucarpidase)
39 No longer available Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer
Condition: Adenocarcinoma of the Prostate
Intervention: Drug: Bicalutamide (Casodex)
40 No longer available An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
Condition: Breast Cancer
Intervention: Drug: iniparib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years